Welcome to the ICCS Website
The fundamental goal of the ICCS is to improve the quality of life and the life expectancy for all growing individuals with deficient bladder function, expressed as problems of storage and evacuation of urine. ICCS intends to approach this goal by increasing knowledge in all aspects of this problem area.
President's Message
Dear ICCS member
I write to you in late August, while preparing for the ICCS workshop that is to be held in conjunction with the 50 year anniversary of the European Society for Pediatric Nephrology (ESPN) in Glasgow, Scotland.
The grand ICCS conference in St Louis, USA, earlier this summer is still fresh in my memory. I think it was even better than anticipated. The city was extremely friendly and welcoming (contradicting my notions of current official US isolationist policies), and our friend Paul Austin ensured that all meeting sessions – as well as the social program – were top class. It will take a lot of Alzheimer’s to make me forget the speakers’ dinner at the cajun blues bar close to the Cardinals’ baseball stadium.... More...
http://www.sap.org.ar/congresos/316/7-congreso-argentino-de-nefrologia-pediatrica.html
https://www.facebook.com/Curso-Incontinencia-Urinaria-Pediatrica-280295719126725/
Local Committee
Ospedale Bambino Gesù, Roma
Urology & Urodynamics
Meeting Info | +39.0523.338391
| iccs2018@defoe.it
Topics
- LUTS
- Enuresis
- Urodynamics
- Neurourology
- Urotherapy
- Neuromodulation
- Drugs for Continence
- Surgery for continence
- Urinary Tract Infections (UTI)
- Bowel and Bladder Disfunction
- Neurogenic Bladder & Bowel in Children & Adolescents
Workshops & Educational Courses
- Workshops on Urodynamics & on Urotherapy | 26 Sep 2018
- Bladder & Bowel Dysfunction in Children to Adulthood | 27 Sep 2018
Industry cooperation statement
The ICCS is an independent, nonprofit organisation aimed at the advancement of research and healthcare. The ICCS Board and associated experts get no payment for their work. The running costs of the ICCS are covered by membership fees and unconditional educational grants from the medical industry.
Foremost among the latter are presently two companies: Ferring Pharmaceuticals and Coloplast, the cooperation with which we hereby gratefully acknowledge. The cooperation is regulated by contracts guaranteeing the independence and protection of both parts, and all matters of common interest are handled by liaison committees, with members from the ICCS and the two companies.
The ICCS members of the ICCS-Ferring liaison committee are Janet Chase, Søren Rittig and Johan Vande Walle. The ICCS members of the ICCS-Coloplast liaison committee are Mario De Gennaro, Søren Rittig and Anka Nieuwhof-Leppink.